Haas-Kogan D - Search Results

1

Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Willers H, Wouters BG, Bernhard EJ. Kirsch DG, et al. J Natl Cancer Inst. 2018 Apr 1;110(4):329-340. doi: 10.1093/jnci/djx231. J Natl Cancer Inst. 2018. PMID: 29126306 Free PMC article.

2

PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter.

Pore N, Liu S, Haas-Kogan DA, O'Rourke DM, Maity A. Pore N, et al. Cancer Res. 2003 Jan 1;63(1):236-41. Cancer Res. 2003. PMID: 12517803

3

Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.

Pore N, Liu S, Shu HK, Li B, Haas-Kogan D, Stokoe D, Milanini-Mongiat J, Pages G, O'Rourke DM, Bernhard E, Maity A. Pore N, et al. Mol Biol Cell. 2004 Nov;15(11):4841-53. doi: 10.1091/mbc.e04-05-0374. Epub 2004 Sep 1. Mol Biol Cell. 2004. PMID: 15342781 Free PMC article.

4

Therapeutic radiation and the potential risk of second malignancies.

Kamran SC, Berrington de Gonzalez A, Ng A, Haas-Kogan D, Viswanathan AN. Kamran SC, et al. Cancer. 2016 Jun 15;122(12):1809-21. doi: 10.1002/cncr.29841. Epub 2016 Mar 7. Cancer. 2016. PMID: 26950597 Free article. Review.

5

Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.

Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, Raben D, Mitchell J. Ahmed MM, et al. Cancer Res. 2018 May 1;78(9):2166-2170. doi: 10.1158/0008-5472.CAN-17-3760. Epub 2018 Apr 23. Cancer Res. 2018. PMID: 29686020 Free PMC article. No abstract available.

6

Clinical Impact of Tumor Mutational Burden in Neuroblastoma.

Hwang WL, Wolfson RL, Niemierko A, Marcus KJ, DuBois SG, Haas-Kogan D. Hwang WL, et al. J Natl Cancer Inst. 2019 Jul 1;111(7):695-699. doi: 10.1093/jnci/djy157. J Natl Cancer Inst. 2019. PMID: 30307503 Free PMC article.

7

Hospice Utilization in Elderly Patients With Brain Metastases.

Mehanna EK, Catalano PJ, Cagney DN, Haas-Kogan DA, Alexander BM, Tulsky JA, Aizer AA. Mehanna EK, et al. J Natl Cancer Inst. 2020 Dec 14;112(12):1251-1258. doi: 10.1093/jnci/djaa036. J Natl Cancer Inst. 2020. PMID: 32163145 Free PMC article.

8

Fas (APO-1/CD95) signaling pathway is intact in radioresistant human glioma cells.

Yount GL, Levine KS, Kuriyama H, Haas-Kogan DA, Israel MA. Yount GL, et al. Cancer Res. 1999 Mar 15;59(6):1362-5. Cancer Res. 1999. PMID: 10096571

9

Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma.

Chen JS, Zhou LJ, Entin-Meer M, Yang X, Donker M, Knight ZA, Weiss W, Shokat KM, Haas-Kogan D, Stokoe D. Chen JS, et al. Mol Cancer Ther. 2008 Apr;7(4):841-50. doi: 10.1158/1535-7163.MCT-07-0393. Mol Cancer Ther. 2008. PMID: 18413797

10

Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults.

Polishchuk AL, Dubois SG, Haas-Kogan D, Hawkins R, Matthay KK. Polishchuk AL, et al. Cancer. 2011 Sep 15;117(18):4286-93. doi: 10.1002/cncr.25987. Epub 2011 Mar 8. Cancer. 2011. PMID: 21387264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page